1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Competitor Analysis: Anti-Obesity Peptides and Biologics

Product description

The present Competitive Intelligence Report about Anti-Obesity Peptides and Biologics used to treat obesity and metabolic syndrome provides a competitor evaluation in the field of R&D projects with anti-obesity peptides and biologics as of February 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. The database also contains information about discontinued projects. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of current active projects in research and development of anti-obesity peptides and biologics such as proteins, antibodies, vaccines, cells, and RNA. In addition, the report lists company-specific R&D pipelines of anti-obesity peptides and biologics. Competitor projects are listed in a tabular format providing information on:
-Drug Codes,
-Target / Mechanism of Action,
-Class of Compound,
-Company,
-Product Category,
-Indication,
-R&D Stage and
-additional comments with a hyperlink leading to the source of information. 

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced. 

Table Of Contents

Competitor Analysis: Anti-Obesity Peptides and Biologics
Table of Contents

--Obesity Peptides
-Anti-Obesity Biologics
-Corporate RandD Pipelines of Anti-Obesity Peptides and Biologics
-About La Merie

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2015

GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2015

  • $ 1 500
  • Industry report
  • October 2015
  • by Global Markets Direct

GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2015’, provides an overview ...

Quest PharmaTech Inc. - Product Pipeline Review - 2015

Quest PharmaTech Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Industry report
  • October 2015
  • by Global Markets Direct

Quest PharmaTech Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Quest PharmaTech Inc. - Product Pipeline Review - 2015’, provides an overview of the Quest PharmaTech Inc.’s ...

CureVac GmbH - Product Pipeline Review - 2015

CureVac GmbH - Product Pipeline Review - 2015

  • $ 1 500
  • Industry report
  • October 2015
  • by Global Markets Direct

CureVac GmbH - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘CureVac GmbH - Product Pipeline Review - 2015’, provides an overview of the CureVac GmbH’s pharmaceutical research ...


Download Unlimited Documents from Trusted Public Sources

Vaccine And Antigen Industry in Europe and the UK

  • December 2015
    36 pages
  • Vaccine  

    Antigen  

    Infectious Dise...  

  • Europe  

    United Kingdom  

    World  

View report >

Biopharmaceutical Industry in the UK

  • November 2015
    9 pages
  • Biopharmaceutic...  

  • United Kingdom  

View report >

Enzyme Industry in the US - Forecast

  • October 2015
    15 pages
  • Enzyme  

  • United States  

View report >

Protein Industry

4 months ago

Related Market Segments :

R&D
Obesity

ref:plp2012

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.